Retrospective assessment of everolimus treatment in patients suffering from advanced renal cell carcinoma
Journal Title: OncoReview - Year 2017, Vol 7, Issue 2
Abstract
Objective: Results of second-line everolimus treatment in clear cell renal carcinoma. Material and methods: Clinical data of 32 patients of the Clinic of Systemic and Metastatic Malignancies, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute (Krakow Branch) treated with second-line everolimus between 2011 and 2016 were analysed. Results: Median progression-free survival was 7 months. Stable disease was observed in 24 cases. Adverse events occurred in 59% of all patients, and the majority were mild and moderate (G1 and G2) according to CTCAE. The most frequent adverse events included anaemia, stomatitis, rash and fatigue. Conclusion: Molecularly targeted drugs offer the only effective and available therapy in Poland, which can be administered in patients with advanced renal cell carcinoma. Second-line everolimus is a valuable therapeutic option in the above mentioned group (following progression on first-line TKI therapy), especially when it is necessary to avoid the accumulation of similar adverse events after TKI treatment (different toxicity profiles).
Authors and Affiliations
Paweł Hernik, Maksymilian Kruczała, Marek Ziobro
Keywords
Related Articles
- EP ID EP189866
- DOI 10.24292/01.OR.300617.6
- Views 212
- Downloads 0
Strategia postępowania z chorymi w fazie przewlekłej PBSz w przypadku niepowodzenia leczenia imatynibem – doświadczenia Kliniki Hematologii w Krakowie
Wstęp: Inhibitory kinaz tyrozynowych w sposób celowany eliminują komórki przewlekłej białaczki szpikowej. Pojawiająca się na nie oporność była przyczyną opracowania rekomendacji terapeutycznych oraz leków drugiej i kolej...
Meeting the human
We often have to deal with problems which force us to making difficult choices and decisions that have not only clinical aspects but also ethical during the oncologist’s work. Unfortunately there is not enough place in a...
The role and place of the health related quality of life in the modern management of lung cancer patients
Quality of life is a personal perception of the individual position held in the life, within the context of culture and value system and in relation to their objectives, expectations and worries. Patients perceptions of...
Przydatność kliniczna pomiaru liczby krążących komórek nowotworowych u chorych na raka piersi
Wstęp: Monitorowanie raka piersi po leczeniu adiuwantowym w szczególnych przypadkach może się opierać na zastosowaniu metod obrazowych lub wykonaniu biopsji. W świetle obecnych badań należy zadać pytanie, czy alternatywn...
Lymphoma-induced hemophagocytic lymphohistiocytosis (HLH)– case report
Hemophagocytic lymphohistiocytosis (HLH) is a rare (especially in adults) syndrome in which hyperinflammation leads to fever, hepatosplenomegaly, pancytopenia and when untreated leads to death. Characteristic laboratory...